{"transactions":[{"id":1562620,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":92730,"kind":"person","name":"Scopelianos Angelo","position":1,"cik":"0001751541","reported_name":"Scopelianos Angelo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Restricted Stock Units","published_at":"2024-03-26T01:37:10.000Z","date":"2024-03-16","kind":"exercise","planned":false,"acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2024 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on March 16, 2022 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2024 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on March 16, 2022 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0000805928-24-000047","document":"wk-form4_1711417017.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592824000047/wk-form4_1711417017.xml","form_type":"4"}},{"id":1562619,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":92730,"kind":"person","name":"Scopelianos Angelo","position":1,"cik":"0001751541","reported_name":"Scopelianos Angelo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Restricted Stock Units","published_at":"2024-03-26T01:37:10.000Z","date":"2024-03-16","kind":"exercise","planned":false,"acquired":false,"shares":4125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2025 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on March 16, 2023, 25% of the aggregate shares vest on March 16, 2024, and 25% of the aggregate shares vest on March 16, 2025. Vested shares will be delivered to the reporting person upon the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2025 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on March 16, 2023, 25% of the aggregate shares vest on March 16, 2024, and 25% of the aggregate shares vest on March 16, 2025. Vested shares will be delivered to the reporting person upon the vesting date."}],"balance_after":4125,"derivative":{"underlying":"Common Stock","underlying_shares":4125},"source":{"system":"sec-edgar","filing":"0000805928-24-000047","document":"wk-form4_1711417017.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592824000047/wk-form4_1711417017.xml","form_type":"4"}},{"id":1562618,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":92730,"kind":"person","name":"Scopelianos Angelo","position":1,"cik":"0001751541","reported_name":"Scopelianos Angelo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Restricted Stock Units","published_at":"2024-03-26T01:37:10.000Z","date":"2024-03-16","kind":"exercise","planned":false,"acquired":false,"shares":21281,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2026 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregateshares vest on March 16, 2024 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2026 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregateshares vest on March 16, 2024 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date."}],"balance_after":21282,"derivative":{"underlying":"Common Stock","underlying_shares":21281},"source":{"system":"sec-edgar","filing":"0000805928-24-000047","document":"wk-form4_1711417017.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592824000047/wk-form4_1711417017.xml","form_type":"4"}},{"id":1562617,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":92730,"kind":"person","name":"Scopelianos Angelo","position":1,"cik":"0001751541","reported_name":"Scopelianos Angelo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Common Stock","published_at":"2024-03-26T01:37:10.000Z","date":"2024-03-21","kind":"sale","planned":false,"acquired":false,"shares":610,"price":7.68,"value":4684.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":57994,"source":{"system":"sec-edgar","filing":"0000805928-24-000047","document":"wk-form4_1711417017.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592824000047/wk-form4_1711417017.xml","form_type":"4"}},{"id":1562616,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":92730,"kind":"person","name":"Scopelianos Angelo","position":1,"cik":"0001751541","reported_name":"Scopelianos Angelo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Common Stock","published_at":"2024-03-26T01:37:10.000Z","date":"2024-03-21","kind":"exercise","planned":false,"acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects the number of restricted stock units that became vested as of March 16, 2024."}],"balance_after":58604,"source":{"system":"sec-edgar","filing":"0000805928-24-000047","document":"wk-form4_1711417017.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592824000047/wk-form4_1711417017.xml","form_type":"4"}},{"id":1562615,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":92730,"kind":"person","name":"Scopelianos Angelo","position":1,"cik":"0001751541","reported_name":"Scopelianos Angelo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Common Stock","published_at":"2024-03-26T01:37:10.000Z","date":"2024-03-21","kind":"sale","planned":false,"acquired":false,"shares":1020,"price":7.68,"value":7833.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":56104,"source":{"system":"sec-edgar","filing":"0000805928-24-000047","document":"wk-form4_1711417017.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592824000047/wk-form4_1711417017.xml","form_type":"4"}},{"id":1562614,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":92730,"kind":"person","name":"Scopelianos Angelo","position":1,"cik":"0001751541","reported_name":"Scopelianos Angelo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Common Stock","published_at":"2024-03-26T01:37:10.000Z","date":"2024-03-16","kind":"exercise","planned":false,"acquired":true,"shares":4125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects the number of restricted stock units that became vested as of March 16, 2024."}],"balance_after":57124,"source":{"system":"sec-edgar","filing":"0000805928-24-000047","document":"wk-form4_1711417017.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592824000047/wk-form4_1711417017.xml","form_type":"4"}},{"id":1562613,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":92730,"kind":"person","name":"Scopelianos Angelo","position":1,"cik":"0001751541","reported_name":"Scopelianos Angelo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Common Stock","published_at":"2024-03-26T01:37:10.000Z","date":"2024-03-21","kind":"sale","planned":false,"acquired":false,"shares":5251,"price":7.68,"value":40327.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":52999,"source":{"system":"sec-edgar","filing":"0000805928-24-000047","document":"wk-form4_1711417017.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592824000047/wk-form4_1711417017.xml","form_type":"4"}},{"id":1562612,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":92730,"kind":"person","name":"Scopelianos Angelo","position":1,"cik":"0001751541","reported_name":"Scopelianos Angelo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Common Stock","published_at":"2024-03-26T01:37:10.000Z","date":"2024-03-16","kind":"exercise","planned":false,"acquired":true,"shares":21281,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects the number of restricted stock units that became vested as of March 16, 2024."}],"balance_after":58250,"source":{"system":"sec-edgar","filing":"0000805928-24-000047","document":"wk-form4_1711417017.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592824000047/wk-form4_1711417017.xml","form_type":"4"}},{"id":1760860,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":92730,"kind":"person","name":"Scopelianos Angelo","position":1,"cik":"0001751541","reported_name":"Scopelianos Angelo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Common Stock","published_at":"2023-10-14T00:28:40.000Z","date":"2023-10-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1403,"price":4.04,"value":5668.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This represents the number of shares of Common Stock that have been withheld by the issuer to satisfy tax withholding and remittance obligations in connection with the net settlement of the PSUs and does not represent an open market sale."}],"balance_after":36969,"source":{"system":"sec-edgar","filing":"0000805928-23-000138","document":"wk-form4_1697243312.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592823000138/wk-form4_1697243312.xml","form_type":"4"}},{"id":1760859,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":92730,"kind":"person","name":"Scopelianos Angelo","position":1,"cik":"0001751541","reported_name":"Scopelianos Angelo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Common Stock","published_at":"2023-10-14T00:28:40.000Z","date":"2023-07-18","kind":"grant","planned":false,"acquired":true,"shares":2571,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects the number of shares issued upon the attainment of certain performance criteria."}],"balance_after":38372,"source":{"system":"sec-edgar","filing":"0000805928-23-000138","document":"wk-form4_1697243312.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592823000138/wk-form4_1697243312.xml","form_type":"4"}},{"id":1945278,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":92730,"kind":"person","name":"Scopelianos Angelo","position":1,"cik":"0001751541","reported_name":"Scopelianos Angelo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Restricted Stock Units","published_at":"2023-03-20T22:27:05.000Z","date":"2023-03-16","kind":"grant","planned":false,"acquired":true,"shares":54100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2027 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregateshares vest on March 16, 2025 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2027 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregateshares vest on March 16, 2025 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date."}],"balance_after":54100,"derivative":{"underlying":"Common Stock","underlying_shares":54100},"source":{"system":"sec-edgar","filing":"0000805928-23-000024","document":"wf-form4_167935121279855.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592823000024/wf-form4_167935121279855.xml","form_type":"4"}},{"id":1945277,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":92730,"kind":"person","name":"Scopelianos Angelo","position":1,"cik":"0001751541","reported_name":"Scopelianos Angelo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Employee Stock Option (right to purchase)","published_at":"2023-03-20T22:27:05.000Z","date":"2023-03-16","kind":"grant","planned":false,"acquired":true,"shares":78000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"All shares of Axogen, Inc. common stock underlying the employee stock option will be fully vested on March 16, 2027 (4 years from the option grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on March 16, 2025 (24 months from the option grant date) and an additional 12.5% of the aggregate shares vest each 6 months thereafter."}],"balance_after":78000,"derivative":{"exercise_price":8.27,"expiration_date":"2033-03-16","underlying":"Common Stock","underlying_shares":78000},"source":{"system":"sec-edgar","filing":"0000805928-23-000024","document":"wf-form4_167935121279855.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592823000024/wf-form4_167935121279855.xml","form_type":"4"}},{"id":1945276,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":92730,"kind":"person","name":"Scopelianos Angelo","position":1,"cik":"0001751541","reported_name":"Scopelianos Angelo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Restricted Stock Units","published_at":"2023-03-20T22:27:05.000Z","date":"2023-03-16","kind":"exercise","planned":false,"acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2024 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on March 16, 2022 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2024 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on March 16, 2022 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date."}],"balance_after":2500,"derivative":{"underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0000805928-23-000024","document":"wf-form4_167935121279855.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592823000024/wf-form4_167935121279855.xml","form_type":"4"}},{"id":1945275,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":92730,"kind":"person","name":"Scopelianos Angelo","position":1,"cik":"0001751541","reported_name":"Scopelianos Angelo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Restricted Stock Units","published_at":"2023-03-20T22:27:05.000Z","date":"2023-03-16","kind":"exercise","planned":false,"acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2024 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on March 16, 2022 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2024 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on March 16, 2022 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date."}],"balance_after":3000,"derivative":{"underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0000805928-23-000024","document":"wf-form4_167935121279855.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592823000024/wf-form4_167935121279855.xml","form_type":"4"}},{"id":1945274,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":92730,"kind":"person","name":"Scopelianos Angelo","position":1,"cik":"0001751541","reported_name":"Scopelianos Angelo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Restricted Stock Units","published_at":"2023-03-20T22:27:05.000Z","date":"2023-03-16","kind":"exercise","planned":false,"acquired":false,"shares":8250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2025 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on March 16, 2023, 25% of the aggregate shares vest on March 16, 2024, and 25% of the aggregate shares vest on March 16, 2025. Vested shares will be delivered to the reporting person upon the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2025 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on March 16, 2023, 25% of the aggregate shares vest on March 16, 2024, and 25% of the aggregate shares vest on March 16, 2025. Vested shares will be delivered to the reporting person upon the vesting date."}],"balance_after":8250,"derivative":{"underlying":"Common Stock","underlying_shares":8250},"source":{"system":"sec-edgar","filing":"0000805928-23-000024","document":"wf-form4_167935121279855.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592823000024/wf-form4_167935121279855.xml","form_type":"4"}},{"id":1945273,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":92730,"kind":"person","name":"Scopelianos Angelo","position":1,"cik":"0001751541","reported_name":"Scopelianos Angelo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Common Stock","published_at":"2023-03-20T22:27:05.000Z","date":"2023-03-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":933,"price":8.27,"value":7715.91,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":35801,"source":{"system":"sec-edgar","filing":"0000805928-23-000024","document":"wf-form4_167935121279855.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592823000024/wf-form4_167935121279855.xml","form_type":"4"}},{"id":1945272,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":92730,"kind":"person","name":"Scopelianos Angelo","position":1,"cik":"0001751541","reported_name":"Scopelianos Angelo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Common Stock","published_at":"2023-03-20T22:27:05.000Z","date":"2023-03-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":778,"price":8.27,"value":6434.06,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":36734,"source":{"system":"sec-edgar","filing":"0000805928-23-000024","document":"wf-form4_167935121279855.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592823000024/wf-form4_167935121279855.xml","form_type":"4"}},{"id":1945271,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":92730,"kind":"person","name":"Scopelianos Angelo","position":1,"cik":"0001751541","reported_name":"Scopelianos Angelo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Common Stock","published_at":"2023-03-20T22:27:05.000Z","date":"2023-03-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":2196,"price":8.27,"value":18160.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":37512,"source":{"system":"sec-edgar","filing":"0000805928-23-000024","document":"wf-form4_167935121279855.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592823000024/wf-form4_167935121279855.xml","form_type":"4"}},{"id":1945270,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":92730,"kind":"person","name":"Scopelianos Angelo","position":1,"cik":"0001751541","reported_name":"Scopelianos Angelo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Common Stock","published_at":"2023-03-20T22:27:05.000Z","date":"2023-03-16","kind":"exercise","planned":false,"acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects the number of restricted stock units that became vested as of March 16, 2023."}],"balance_after":39708,"source":{"system":"sec-edgar","filing":"0000805928-23-000024","document":"wf-form4_167935121279855.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592823000024/wf-form4_167935121279855.xml","form_type":"4"}},{"id":1945269,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":92730,"kind":"person","name":"Scopelianos Angelo","position":1,"cik":"0001751541","reported_name":"Scopelianos Angelo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Common Stock","published_at":"2023-03-20T22:27:05.000Z","date":"2023-03-16","kind":"exercise","planned":false,"acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects the number of restricted stock units that became vested as of March 16, 2023."}],"balance_after":37208,"source":{"system":"sec-edgar","filing":"0000805928-23-000024","document":"wf-form4_167935121279855.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592823000024/wf-form4_167935121279855.xml","form_type":"4"}},{"id":1945268,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":92730,"kind":"person","name":"Scopelianos Angelo","position":1,"cik":"0001751541","reported_name":"Scopelianos Angelo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Common Stock","published_at":"2023-03-20T22:27:05.000Z","date":"2023-03-16","kind":"exercise","planned":false,"acquired":true,"shares":8250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects the number of restricted stock units that became vested as of March 16, 2023."}],"balance_after":34208,"source":{"system":"sec-edgar","filing":"0000805928-23-000024","document":"wf-form4_167935121279855.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592823000024/wf-form4_167935121279855.xml","form_type":"4"}},{"id":2075268,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":92730,"kind":"person","name":"Scopelianos Angelo","position":1,"cik":"0001751541","reported_name":"Scopelianos Angelo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Restricted Stock Units","published_at":"2022-12-30T01:40:16.000Z","date":"2022-12-27","kind":"exercise","acquired":true,"shares":1150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"All shares of AxoGen Inc. common stock underlying the restricted stock units vested on December 27, 2022 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on December 27, 2020 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"All shares of AxoGen Inc. common stock underlying the restricted stock units vested on December 27, 2022 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on December 27, 2020 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1150},"source":{"system":"sec-edgar","filing":"0000805928-22-000137","document":"wf-form4_167236440298967.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592822000137/wf-form4_167236440298967.xml","form_type":"4"}},{"id":2075267,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":92730,"kind":"person","name":"Scopelianos Angelo","position":1,"cik":"0001751541","reported_name":"Scopelianos Angelo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Common Stock","published_at":"2022-12-30T01:40:16.000Z","date":"2022-12-27","kind":"tax_withholding","acquired":false,"shares":286,"price":9.44,"value":2699.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":25958,"source":{"system":"sec-edgar","filing":"0000805928-22-000137","document":"wf-form4_167236440298967.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592822000137/wf-form4_167236440298967.xml","form_type":"4"}},{"id":2075266,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":92730,"kind":"person","name":"Scopelianos Angelo","position":1,"cik":"0001751541","reported_name":"Scopelianos Angelo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Common Stock","published_at":"2022-12-30T01:40:16.000Z","date":"2022-12-27","kind":"exercise","acquired":true,"shares":1150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This reflects the number of restricted stock units that vested on December 27, 2022."}],"balance_after":26244,"source":{"system":"sec-edgar","filing":"0000805928-22-000137","document":"wf-form4_167236440298967.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592822000137/wf-form4_167236440298967.xml","form_type":"4"}},{"id":2204832,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":92730,"kind":"person","name":"Scopelianos Angelo","position":1,"cik":"0001751541","reported_name":"Scopelianos Angelo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Common Stock","published_at":"2022-07-20T20:04:52.000Z","date":"2022-07-19","kind":"disposition_to_issuer","acquired":false,"shares":657,"price":8.4,"value":5518.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The reported shares were sold, in compliance with company policy as to delivery of compensation based equity, with proceeds from such being used to cover the Reporting Person's tax withholding liability in connection with a portion of a performance stock award that vested on July 19, 2022."}],"balance_after":25094,"source":{"system":"sec-edgar","filing":"0000805928-22-000094","document":"wf-form4_165834747880252.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592822000094/wf-form4_165834747880252.xml","form_type":"4"}},{"id":2204831,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":92730,"kind":"person","name":"Scopelianos Angelo","position":1,"cik":"0001751541","reported_name":"Scopelianos Angelo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Common Stock","published_at":"2022-07-20T20:04:52.000Z","date":"2022-07-18","kind":"grant","acquired":true,"shares":2571,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects the number of shares that vested on July 18, 2022 upon the attainment of certain performance criteria."}],"balance_after":22751,"source":{"system":"sec-edgar","filing":"0000805928-22-000094","document":"wf-form4_165834747880252.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592822000094/wf-form4_165834747880252.xml","form_type":"4"}},{"id":2325604,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":92730,"kind":"person","name":"Scopelianos Angelo","position":1,"cik":"0001751541","reported_name":"Scopelianos Angelo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Employee Stock Option (right to purchase)","published_at":"2022-03-18T20:11:13.000Z","date":"2022-03-16","kind":"grant","acquired":true,"shares":39700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"All shares of Axogen, Inc. common stock underlying the employee stock option will be fully vested on March 16, 2026 (4 years from the option grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on March 16, 2024 (24 months from the option grant date) and an additional 12.5% of the aggregate shares vest each 6 months thereafter."}],"balance_after":39700,"derivative":{"exercise_price":8.2,"expiration_date":"2032-03-16","underlying":"Common Stock","underlying_shares":39700},"source":{"system":"sec-edgar","filing":"0000805928-22-000034","document":"wf-form4_164763424502227.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592822000034/wf-form4_164763424502227.xml","form_type":"4"}},{"id":2325603,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":92730,"kind":"person","name":"Scopelianos Angelo","position":1,"cik":"0001751541","reported_name":"Scopelianos Angelo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Restricted Stock Units","published_at":"2022-03-18T20:11:13.000Z","date":"2022-03-16","kind":"grant","acquired":true,"shares":42563,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2026 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregateshares vest on March 16, 2024 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2026 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregateshares vest on March 16, 2024 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date."}],"balance_after":42563,"derivative":{"underlying":"Common Stock","underlying_shares":42563},"source":{"system":"sec-edgar","filing":"0000805928-22-000034","document":"wf-form4_164763424502227.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592822000034/wf-form4_164763424502227.xml","form_type":"4"}},{"id":2325602,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":92730,"kind":"person","name":"Scopelianos Angelo","position":1,"cik":"0001751541","reported_name":"Scopelianos Angelo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Restricted Stock Units","published_at":"2022-03-18T20:11:13.000Z","date":"2022-03-16","kind":"exercise","acquired":false,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2024 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on March 16, 2022 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2024 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on March 16, 2022 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date."}],"balance_after":11000,"derivative":{"exercise_date":"2024-03-16","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0000805928-22-000034","document":"wf-form4_164763424502227.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592822000034/wf-form4_164763424502227.xml","form_type":"4"}},{"id":2325601,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":92730,"kind":"person","name":"Scopelianos Angelo","position":1,"cik":"0001751541","reported_name":"Scopelianos Angelo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Common Stock","published_at":"2022-03-18T20:11:13.000Z","date":"2022-03-16","kind":"tax_withholding","acquired":false,"shares":2770,"price":7.97,"value":22076.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":20180,"source":{"system":"sec-edgar","filing":"0000805928-22-000034","document":"wf-form4_164763424502227.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592822000034/wf-form4_164763424502227.xml","form_type":"4"}},{"id":2325600,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":92730,"kind":"person","name":"Scopelianos Angelo","position":1,"cik":"0001751541","reported_name":"Scopelianos Angelo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Common Stock","published_at":"2022-03-18T20:11:13.000Z","date":"2022-03-16","kind":"exercise","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects the number of restricted stock units that became vested as of March 16, 2022."}],"balance_after":22950,"source":{"system":"sec-edgar","filing":"0000805928-22-000034","document":"wf-form4_164763424502227.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592822000034/wf-form4_164763424502227.xml","form_type":"4"}},{"id":2390276,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":92730,"kind":"person","name":"Scopelianos Angelo","position":1,"cik":"0001751541","reported_name":"Scopelianos Angelo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Common Stock","published_at":"2022-02-17T21:11:26.000Z","date":"2022-02-15","kind":"tax_withholding","acquired":false,"shares":400,"price":8.42,"value":3368.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The reported shares were sold, in compliance with company policy as to delivery of compensation based equity, with proceeds from such being used to cover the Reporting Person's tax withholding liability in connection with a portion of a performance stock award that vested on February 15, 2022."}],"balance_after":11950,"source":{"system":"sec-edgar","filing":"0000805928-22-000013","document":"wf-form4_164513225128430.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592822000013/wf-form4_164513225128430.xml","form_type":"4"}},{"id":2390275,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":92730,"kind":"person","name":"Scopelianos Angelo","position":1,"cik":"0001751541","reported_name":"Scopelianos Angelo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Common Stock","published_at":"2022-02-17T21:11:26.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":1325,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects the number of shares that became vested as of February 15, 2022 upon the attainment of certain performance criteria."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 41 shares acquired under the Axogen stock purchase plan on December 31, 2021."}],"balance_after":12350,"source":{"system":"sec-edgar","filing":"0000805928-22-000013","document":"wf-form4_164513225128430.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592822000013/wf-form4_164513225128430.xml","form_type":"4"}},{"id":2457524,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":92730,"kind":"person","name":"Scopelianos Angelo","position":1,"cik":"0001751541","reported_name":"Scopelianos Angelo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Restricted Stock Units","published_at":"2021-12-29T21:31:01.000Z","date":"2021-12-27","kind":"exercise","acquired":false,"shares":1150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"All shares of AxoGen Inc. common stock underlying the restricted stock Units will be fully vested on December 27, 2022 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on December 27, 2020 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"All shares of AxoGen Inc. common stock underlying the restricted stock Units will be fully vested on December 27, 2022 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on December 27, 2020 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date."}],"balance_after":1150,"derivative":{"exercise_date":"2022-12-27","expiration_date":"2022-12-27","underlying":"Common Stock","underlying_shares":2300},"source":{"system":"sec-edgar","filing":"0000805928-21-000184","document":"wf-form4_164081344903243.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592821000184/wf-form4_164081344903243.xml","form_type":"4"}},{"id":2457523,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":92730,"kind":"person","name":"Scopelianos Angelo","position":1,"cik":"0001751541","reported_name":"Scopelianos Angelo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Common Stock","published_at":"2021-12-29T21:31:01.000Z","date":"2021-12-27","kind":"tax_withholding","acquired":false,"shares":286,"price":9.74,"value":2785.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":10984,"source":{"system":"sec-edgar","filing":"0000805928-21-000184","document":"wf-form4_164081344903243.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592821000184/wf-form4_164081344903243.xml","form_type":"4"}},{"id":2457522,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":92730,"kind":"person","name":"Scopelianos Angelo","position":1,"cik":"0001751541","reported_name":"Scopelianos Angelo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Common Stock","published_at":"2021-12-29T21:31:01.000Z","date":"2021-12-27","kind":"exercise","acquired":true,"shares":1150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects the number of restricted stock units that vested on December 27, 2021."}],"balance_after":11270,"source":{"system":"sec-edgar","filing":"0000805928-21-000184","document":"wf-form4_164081344903243.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592821000184/wf-form4_164081344903243.xml","form_type":"4"}},{"id":2628769,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":92730,"kind":"person","name":"Scopelianos Angelo","position":1,"cik":"0001751541","reported_name":"Scopelianos Angelo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Common Stock","published_at":"2021-07-21T20:14:18.000Z","date":"2021-07-20","kind":"tax_withholding","acquired":false,"shares":637,"price":19.2,"value":12230.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The reported shares were sold, in compliance with company policy as to delivery of compensation based equity, with proceeds from such being used to cover the Reporting Person's tax withholding liability in connection with a portion of a performance stock award that vested on July 19, 2021."}],"balance_after":10120,"source":{"system":"sec-edgar","filing":"0000805928-21-000144","document":"wf-form4_162689844445878.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592821000144/wf-form4_162689844445878.xml","form_type":"4"}},{"id":2628768,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":92730,"kind":"person","name":"Scopelianos Angelo","position":1,"cik":"0001751541","reported_name":"Scopelianos Angelo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Common Stock","published_at":"2021-07-21T20:14:18.000Z","date":"2021-07-19","kind":"grant","acquired":true,"shares":2572,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects the number of shares that became vested as of July 19, 2021 upon the attainment of certain performance criteria."}],"balance_after":10757,"source":{"system":"sec-edgar","filing":"0000805928-21-000144","document":"wf-form4_162689844445878.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592821000144/wf-form4_162689844445878.xml","form_type":"4"}},{"id":2780298,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":92730,"kind":"person","name":"Scopelianos Angelo","position":1,"cik":"0001751541","reported_name":"Scopelianos Angelo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Restricted Stock Units","published_at":"2021-03-18T21:53:13.000Z","date":"2021-03-16","kind":"grant","acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2025 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on March 16, 2023 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2025 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on March 16, 2023 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date."}],"balance_after":16500,"derivative":{"underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0000805928-21-000057","document":"wf-form4_161610437741856.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592821000057/wf-form4_161610437741856.xml","form_type":"4"}},{"id":2780297,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":92730,"kind":"person","name":"Scopelianos Angelo","position":1,"cik":"0001751541","reported_name":"Scopelianos Angelo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Employee Stock Option (right to purchase)","published_at":"2021-03-18T21:53:13.000Z","date":"2021-03-16","kind":"grant","acquired":true,"shares":34000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All shares of Axogen, Inc. common stock underlying the employee stock option will be fully vested on March 16, 2025 (4 years from the option grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on March 16, 2023 (24 months from the option grant date) and an additional 12.5% of the aggregate shares vest each 6 months thereafter."}],"balance_after":34000,"derivative":{"exercise_price":20.91,"expiration_date":"2031-03-16","underlying":"Common Stock","underlying_shares":34000},"source":{"system":"sec-edgar","filing":"0000805928-21-000057","document":"wf-form4_161610437741856.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592821000057/wf-form4_161610437741856.xml","form_type":"4"}},{"id":2852447,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":92730,"kind":"person","name":"Scopelianos Angelo","position":1,"cik":"0001751541","reported_name":"Scopelianos Angelo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Common Stock","published_at":"2021-02-18T22:27:24.000Z","date":"2021-02-17","kind":"tax_withholding","acquired":false,"shares":406,"price":18.71,"value":7596.26,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The reported shares were sold, in compliance with company policy as to delivery of compensation based equity, with proceeds from such being used to cover the Reporting Person's tax withholding liability in connection with a portion of a performance stock award that vested on February 16, 2021."}],"balance_after":7046,"source":{"system":"sec-edgar","filing":"0000805928-21-000029","document":"wf-form4_161368721919283.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592821000029/wf-form4_161368721919283.xml","form_type":"4"}},{"id":2852446,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":92730,"kind":"person","name":"Scopelianos Angelo","position":1,"cik":"0001751541","reported_name":"Scopelianos Angelo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Common Stock","published_at":"2021-02-18T22:27:24.000Z","date":"2021-02-16","kind":"grant","acquired":true,"shares":1325,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects the number of shares that became vested as of February 16, 2021 upon the attainment of certain performance criteria."}],"balance_after":7452,"source":{"system":"sec-edgar","filing":"0000805928-21-000029","document":"wf-form4_161368721919283.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592821000029/wf-form4_161368721919283.xml","form_type":"4"}},{"id":2929701,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":92730,"kind":"person","name":"Scopelianos Angelo","position":1,"cik":"0001751541","reported_name":"Scopelianos Angelo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Research & Development"}}],"security":"Common Stock","published_at":"2020-12-30T16:55:42.000Z","date":"2020-12-29","kind":"sale","acquired":false,"shares":567,"price":17.81,"value":10098.27,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units granted on December 27, 2018. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":5529,"source":{"system":"sec-edgar","filing":"0001179110-20-012287","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911020012287/edgar.xml","form_type":"4"}},{"id":2929700,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":92730,"kind":"person","name":"Scopelianos Angelo","position":1,"cik":"0001751541","reported_name":"Scopelianos Angelo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Research & Development"}}],"security":"Common Stock","published_at":"2020-12-30T16:55:42.000Z","date":"2020-12-27","kind":"grant","acquired":true,"shares":2300,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects the number of restricted stock units that became vested as of December 27, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This reflects the number of restricted stock units that became vested as of December 27, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 1547 shares acquired under the Axogen, Inc. employee stock purchase plan on June 30, 2020."}],"balance_after":6096,"source":{"system":"sec-edgar","filing":"0001179110-20-012287","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911020012287/edgar.xml","form_type":"4"}},{"id":3203626,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":92730,"kind":"person","name":"Scopelianos Angelo","position":1,"cik":"0001751541","reported_name":"Scopelianos Angelo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Research & Development"}}],"security":"Restricted Stock Units","published_at":"2020-03-18T21:13:11.000Z","date":"2020-03-16","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2024 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on March 16, 2022 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2024 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on March 16, 2022 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date."}],"balance_after":22000,"derivative":{"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001179110-20-003909","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911020003909/edgar.xml","form_type":"4"}},{"id":3203625,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":92730,"kind":"person","name":"Scopelianos Angelo","position":1,"cik":"0001751541","reported_name":"Scopelianos Angelo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Research & Development"}}],"security":"Restricted Stock Units","published_at":"2020-03-18T21:13:11.000Z","date":"2020-03-16","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2024 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on March 16, 2022 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2024 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on March 16, 2022 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date."}],"balance_after":12000,"derivative":{"underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001179110-20-003909","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911020003909/edgar.xml","form_type":"4"}},{"id":3203624,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":92730,"kind":"person","name":"Scopelianos Angelo","position":1,"cik":"0001751541","reported_name":"Scopelianos Angelo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Research & Development"}}],"security":"Employee Stock Option (right to purchase)","published_at":"2020-03-18T21:13:11.000Z","date":"2020-03-16","kind":"grant","acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All shares of Axogen, Inc. common stock underlying the employee stock option will be fully vested on March 16, 2024 (4 years from the option grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on March 16, 2022 (24 months from the option grant date) and an additional 12.5% of the aggregate shares vest each 6 months thereafter."}],"balance_after":24000,"derivative":{"exercise_price":8.61,"expiration_date":"2030-03-16","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001179110-20-003909","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911020003909/edgar.xml","form_type":"4"}},{"id":3261038,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":92730,"kind":"person","name":"Scopelianos Angelo","position":1,"cik":"0001751541","reported_name":"Scopelianos Angelo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Research & Development"}}],"security":"Common Stock","published_at":"2020-02-20T21:17:10.000Z","date":"2020-02-18","kind":"tax_withholding","acquired":false,"shares":394,"price":14.68,"value":5783.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a performance stock award that vested on February 18, 2020."}],"balance_after":2249,"source":{"system":"sec-edgar","filing":"0001179110-20-001955","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911020001955/edgar.xml","form_type":"4"}},{"id":3261037,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":92730,"kind":"person","name":"Scopelianos Angelo","position":1,"cik":"0001751541","reported_name":"Scopelianos Angelo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Research & Development"}}],"security":"Common Stock","published_at":"2020-02-20T21:17:10.000Z","date":"2020-02-18","kind":"grant","acquired":true,"shares":1326,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects the number of shares that became vested as of February 18, 2020 upon the attainment of certain performance criteria."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This reflects the number of shares that became vested as of February 18, 2020 upon the attainment of certain performance criteria."}],"balance_after":2643,"source":{"system":"sec-edgar","filing":"0001179110-20-001955","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911020001955/edgar.xml","form_type":"4"}},{"id":3716540,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":92730,"kind":"person","name":"Scopelianos Angelo","position":1,"cik":"0001751541","reported_name":"Scopelianos Angelo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Research & Development"}}],"security":"Restricted Stock Units","published_at":"2018-12-31T21:36:22.000Z","date":"2018-12-27","kind":"grant","acquired":true,"shares":4600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of AxoGen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All shares of AxoGen Inc. common stock underlying the restricted stock Units will be fully vested on December 27, 2022 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on December 27, 2020 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"All shares of AxoGen Inc. common stock underlying the restricted stock Units will be fully vested on December 27, 2022 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on December 27, 2020 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date."}],"balance_after":4600,"derivative":{"underlying":"Common Stock","underlying_shares":4600},"source":{"system":"sec-edgar","filing":"0001179110-18-014319","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911018014319/edgar.xml","form_type":"4"}},{"id":3716539,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":92730,"kind":"person","name":"Scopelianos Angelo","position":1,"cik":"0001751541","reported_name":"Scopelianos Angelo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Research & Development"}}],"security":"Employee Stock Option (right to purchase)","published_at":"2018-12-31T21:36:22.000Z","date":"2018-12-27","kind":"grant","acquired":true,"shares":32900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All shares of AxoGen, Inc. common stock underlying the employee stock option will be fully vested on December 27, 2022 (4 years from the option grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on December 27, 2020 (24 months from the option grant date) and an additional 12.5% of the aggregate shares vest each 6 months thereafter."}],"balance_after":32900,"derivative":{"exercise_price":19.17,"expiration_date":"2028-12-27","underlying":"Common Stock","underlying_shares":32900},"source":{"system":"sec-edgar","filing":"0001179110-18-014319","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911018014319/edgar.xml","form_type":"4"}},{"id":3826400,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":92730,"kind":"person","name":"Scopelianos Angelo","position":1,"cik":"0001751541","reported_name":"Scopelianos Angelo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Research & Development"}}],"security":"Employee Stock Option (right to purchase)","published_at":"2018-09-05T21:12:08.000Z","date":"2018-09-04","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All shares of AxoGen, Inc. common stock underlying the employee stock option will be fully vested on September 4, 2022 (4 years from the option grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on September 4, 2020 (24 months from the option grant date) and an additional 12.5% of the aggregate shares vest each 6 months thereafter."}],"balance_after":40000,"derivative":{"exercise_price":45,"expiration_date":"2028-09-04","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001182489-18-000359","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000118248918000359/edgar.xml","form_type":"4"}}]}